Literature DB >> 1536963

Donor leukocyte infusions for chronic myeloid leukemia in relapse after allogeneic bone marrow transplantation.

J O Cullis, Y Z Jiang, A P Schwarer, T P Hughes, A J Barrett, J M Goldman.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1536963

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  8 in total

Review 1.  Role of donor lymphocyte infusions in relapsed hematological malignancies after stem cell transplantation revisited.

Authors:  Abhinav Deol; Lawrence G Lum
Journal:  Cancer Treat Rev       Date:  2010-04-09       Impact factor: 12.111

Review 2.  CARs in chronic lymphocytic leukemia -- ready to drive.

Authors:  Chitra Hosing; Partow Kebriaei; William Wierda; Bipulendu Jena; Laurence J N Cooper; Elizabeth Shpall
Journal:  Curr Hematol Malig Rep       Date:  2013-03       Impact factor: 3.952

3.  Early administration of donor lymphocyte infusions upon molecular relapse after allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia: a study by the Chronic Malignancies Working Party of the EBMT.

Authors:  Yves Chalandon; Jakob R Passweg; Cesare Guglielmi; Simona Iacobelli; Jane Apperley; Nicolaas P M Schaap; Jürgen Finke; Marie Robin; Roberta Fedele; Dominique Bron; Ibrahim Yakoub-Agha; Anja van Biezen; Theo de Witte; Nicolaus Kröger; Eduardo Olavarria
Journal:  Haematologica       Date:  2014-07-04       Impact factor: 9.941

4.  Antigens shared by malignant plasma cells and normal B cells may be involved in graft versus myeloma.

Authors:  P A Holloway; N Kaldenhoven; H M Kok-Schoemaker; B Van Kessel; W T M Van Blokland; A C Bloem; H M Lokhorst
Journal:  Clin Exp Immunol       Date:  2003-02       Impact factor: 4.330

Review 5.  Graft-versus-leukemia and graft-versus-lymphoma effects of allogeneic bone marrow transplantation and of allogeneic donor leukocyte transfusions.

Authors:  P Vandenberghe; M A Boogaerts
Journal:  Ann Hematol       Date:  1995-11       Impact factor: 3.673

Review 6.  The Emerging Landscape of Immune Cell Therapies.

Authors:  Evan W Weber; Marcela V Maus; Crystal L Mackall
Journal:  Cell       Date:  2020-04-02       Impact factor: 41.582

Review 7.  Chimeric antibody receptors (CARs): driving T-cell specificity to enhance anti-tumor immunity.

Authors:  Partow Kebriaei; Susan S Kelly; Pallavi Manuri; Bipulendu Jena; Rineka Jackson; Elizabeth Shpall; Richard Champlin; Laurence J N Cooper
Journal:  Front Biosci (Schol Ed)       Date:  2012-01-01

8.  BCR-ABL1 transcripts (MR4.5) at post-transplant 3 months as an early predictor for long-term outcomes in chronic myeloid leukemia.

Authors:  Sung-Eun Lee; Soo Young Choi; Soo-Hyun Kim; Hye-Young Song; Hea-Lyun Yoo; Mi-Young Lee; Ki-Hoon Kang; Hee-Jeong Hwang; Eun-Jung Jang; Dong-Wook Kim
Journal:  Korean J Intern Med       Date:  2016-06-22       Impact factor: 2.884
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.